Investigational Site Number :1580008

Taichung 40201

0 studies enrolling now · 2 studies all time

What they study most

Hemophilia, Neurodermatitis

Studies at this site

• Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX — Running, not enrolling
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed